[1]
|
Chamot AM, Benhamou CL, Kahn MF, et al. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey 85 cases[J]. Rev Rhum Mal Osteoartic, 1987, 54:187-196. http://europepmc.org/abstract/MED/2954204 |
[2]
|
Colina M, Govoni M, Orzincolo C, et al. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome:a single center study of a cohort of 71 subjects[J]. Arthritis Care Res, 2009, 61:813-821. doi: 10.1002/art.24540 |
[3]
|
Magrey M, Khan MA. New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome[J]. Curr Rheumatol Rep, 2009, 11:329-333. doi: 10.1007/s11926-009-0047-8 |
[4]
|
Salles M, Olive A, Perez-Andres R, et al. The SAPHO syndrome:a clinical and imaging study[J]. Clin Rheumatol, 2011, 30:245-249. doi: 10.1007/s10067-010-1560-x |
[5]
|
Earwaker JW, Cotten A. SAPHO:syndrome or concept? Ima-ging findings[J]. Skeletal Radiol, 2003, 32:311-327. doi: 10.1007/s00256-003-0629-x |
[6]
|
Pichler R, Weiglein K, Schmekal B, et al. Bone scintigraphy using Tc-99m DPD and F18-FDG in a patient with SAPHO syndrome[J]. Scand J Rheumatol, 2003, 32:58-60. doi: 10.1080/03009740310000436 |
[7]
|
Patel CN, Smith JT, Rankine JJ, et al. F-18 FDG PET/CT can help differentiate SAPHO syndrome from suspected metastatic bone disease[J]. Clin Nucl Med, 2009, 34:254-257. doi: 10.1097/RLU.0b013e31819a205c |
[8]
|
Inoue K, Yamaguchi T, Ozawa H, et al. Diagnosing active inflammation in the SAPHO syndrome using 18FDG-PET/CT in suspected metastatic vertebral bone tumors[J]. Ann Nucl Med, 2007, 21:477-480. doi: 10.1007/s12149-007-0051-x |